ZIVO BIOSCIENCE, INC. — Earnings

Most recent reported period: FY2025 (Q3) (filed for period ending 2025-09-30) · sourced from SEC EDGAR

Next earnings (estimated): Tue, December 30, 2025 — 119 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.

Recent · last 8 quarters Future · next 8 quarters

YoY = vs same quarter prior year (seasonality-adjusted)

Quarter end	Revenue	YoY	Net Income	YoY	Op. Margin
2025-09-30	$66K	↑+108.3%	$-1M	↑+54.5%	-1551.8%
2025-06-30	$53K	—	$-2M	↑+80.1%	-3057.8%
2025-03-31	$0	↓-100.0%	$-4M	↓-229.4%	—
2024-12-31	$90K	↑+662.7%	—	—	—
2024-09-30	$32K	↑+166.9%	$-2M	↓-24.3%	-7174.7%
2024-06-30	$0	↓-100.0%	$-8M	↓-297.8%	—
2024-03-31	$36K	—	$-1M	↑+35.2%	-3571.8%
2023-12-31	$12K	—	—	—	—

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q3)

Revenue

$66K

↑+108.3% +$34K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.